CBAN vs CARE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 20, 2026
CBAN
CARE
Investment Advisor Scores
CARE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CBAN | CARE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.0011 | 13.6612 | CBAN |
| PEG Ratio | 2.1066 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 33.9% | 260.0% | CARE |
| Earnings Growth | 2.4% | 900.8% | CARE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 60.5/100 | 52.2/100 | CBAN |
| Profit Margin | 21.7% | 41.8% | CARE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | CBAN |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CBAN
MarkupPrice above SMA50, rising 50-day trend (2.7% over 20 days), RSI 61
CARE
MarkupPrice above SMA50, rising 50-day trend (10.5% over 20 days), RSI 70
Fundamentals Snapshot
| Metric | CBAN | CARE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 9.3 | 13.8 |
| Trailing P/E | 13.2 | 6.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.7% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.4% | 0.6% |
| EPS | 1.66 | 5.80 |
| Dividend Yield | 0.02% | 0.00% |